Vanguard Group’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.15M | Sell |
138,194
-87,016
| -39% | -$482K | ﹤0.01% | 3738 |
|
|
2025
Q3 | $971K | Buy |
225,210
+8,379
| +4% | +$50.5K | ﹤0.01% | 3796 |
|
|
2025
Q2 | $1.15M | Sell |
216,831
-19,301
| -8% | -$104K | ﹤0.01% | 3705 |
|
|
2025
Q1 | $1.04M | Buy |
236,132
+48,141
| +26% | +$311K | ﹤0.01% | 3697 |
|
|
2024
Q4 | $1.32M | Buy |
187,991
+59,331
| +46% | +$652K | ﹤0.01% | 3677 |
|
|
2024
Q3 | $1.87M | Buy |
128,660
+1,713
| +1% | +$77.1K | ﹤0.01% | 3577 |
|
|
2024
Q2 | $9.25M | Buy |
126,947
+76
| +0.1% | +$5.84K | ﹤0.01% | 2978 |
|
|
2024
Q1 | $7.51M | Buy |
126,871
+761
| +0.6% | +$42K | ﹤0.01% | 3119 |
|
|
2023
Q4 | $9.23M | Buy |
126,110
+3,424
| +3% | +$141K | ﹤0.01% | 2987 |
|
|
2023
Q3 | $4.77M | Buy |
122,686
+242
| +0.2% | +$12.3K | ﹤0.01% | 3271 |
|
|
2023
Q2 | $7.07M | Buy |
122,444
+10,666
| +10% | +$648K | ﹤0.01% | 3138 |
|
|
2023
Q1 | $7.27M | Buy |
111,778
+9,499
| +9% | +$575K | ﹤0.01% | 3125 |
|
|
2022
Q4 | $2.81M | Buy |
102,279
+1,019
| +1% | +$27.2K | ﹤0.01% | 3539 |
|
|
2022
Q3 | $2.96M | Hold |
101,260
| – | – | ﹤0.01% | 3593 |
|
|
2022
Q2 | $1.95M | Buy |
101,260
+32,044
| +46% | +$1.61M | ﹤0.01% | 3819 |
|
|
2022
Q1 | $5.61M | Sell |
69,216
-4
| -0% | -$330 | ﹤0.01% | 3472 |
|
|
2021
Q4 | $6.34M | Buy |
69,220
+2
| +0% | +$227 | ﹤0.01% | 3482 |
|
|
2021
Q3 | $8.65M | Buy |
69,218
+437
| +0.6% | +$49K | ﹤0.01% | 3334 |
|
|
2021
Q2 | $7.77M | Sell |
68,781
-2,287
| -3% | -$277K | ﹤0.01% | 3342 |
|
|
2021
Q1 | $10.8M | Buy |
71,068
+11,503
| +19% | +$1.59M | ﹤0.01% | 3103 |
|
|
2020
Q4 | $6.86M | Buy |
59,565
+931
| +2% | +$85.6K | ﹤0.01% | 3189 |
|
|
2020
Q3 | $4.54M | Sell |
58,634
-916
| -2% | -$75K | ﹤0.01% | 3198 |
|
|
2020
Q2 | $6.56M | Buy |
59,550
+1,601
| +3% | +$185K | ﹤0.01% | 2973 |
|
|
2020
Q1 | $6.33M | Buy |
57,949
+705
| +1% | +$92.8K | ﹤0.01% | 2848 |
|
|
2019
Q4 | $9.1M | Buy |
57,244
+2,880
| +5% | +$425K | ﹤0.01% | 2903 |
|
|
2019
Q3 | $8.02M | Buy |
54,364
+8,654
| +19% | +$964K | ﹤0.01% | 2928 |
|
|
2019
Q2 | $5.31M | Buy |
45,710
+2,585
| +6% | +$242K | ﹤0.01% | 3147 |
|
|
2019
Q1 | $4.66M | Buy |
43,125
+2,601
| +6% | +$300K | ﹤0.01% | 3165 |
|
|
2018
Q4 | $3.3M | Buy |
40,524
+11,275
| +39% | +$1.37M | ﹤0.01% | 3222 |
|
|
2018
Q3 | $4.75M | Buy |
29,249
+26,465
| +951% | +$4.52M | ﹤0.01% | 3257 |
|
|
2018
Q2 | $549K | Buy |
+2,784
| New | +$545K | ﹤0.01% | 3807 |
|
Other funds holding VRCA
AC
CP
AAA
VCIM
SCM
BFM
KCM
DCM
